Johnson & Johnson Innovation
Last update: October 2, 2020
Biotechnology
United States (USA)
Its 42 main executivesIts subsidiary
Recent executive movements at Johnson & Johnson Innovation
Avrum Spira has joined the company as Global Head, Lung Cancer Initiative (news posted on October 2 2020).
Harpal Kumar, Head of EMEA, has left the company (news posted on April 10 2020).
Create an alert
to follow the executive moves at Johnson & Johnson Innovation.
Most searched biographies at Johnson & Johnson Innovation
- Chris Picariello, President
- Maike Stenull, Global Head of Strategy and Business Operations
- Melinda Richter, Global Head of JLabs
Click on an executive to view his biography >
Latest M&A news in Biotechnology.
Sunesis Pharmaceuticals has announced the acquisition of Viracta Therapeutics (posted on Nov 30, 2020).
Novo Nordisk has announced the acquisition of Emisphere Technologies (posted on Nov 10, 2020).
Sanofi has acquired Kiadis Pharma (posted on Nov 3, 2020).
Other contacts in the Biotechnology industry
Latest news about Johnson & Johnson Innovation
ViaCyte Announces $27 Million Financing to Advance Next Generation Cell Therapies for Diabetes
Fate Therapeutics Announces Worldwide Collaboration with Janssen for Novel iPSC-derived Cell-based Cancer Immunotherapies | Fate Therapeutics, Inc.
OrthoSpin Ltd. Raises up to US$5 Million in Series B Financing
Concerto HealthAI Establishes Real-World Data and AI Collaboration with Janssen
Johnson & Johnson Announces Agreement to Acquire Remaining Stake in Verb Surgical Inc.
Johnson & Johnson Innovation on Wikipedia, Google News & Yahoo Finance
Johnson & Johnson Innovation on LinkedIn, Twitter & YouTube
Johnson & Johnson Innovation has 1,507 competitors including Agilyx (United States (USA)), Biogen (United States (USA)) and Eurofins (France). Johnson & Johnson Innovation is owned by Johnson & Johnson.
Contact by email its executives including Chris Picariello 
Call Johnson & Johnson Innovation at +1 732....
